scispace - formally typeset
W

William Benjamin Smith

Researcher at University of California, San Francisco

Publications -  10
Citations -  211

William Benjamin Smith is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Vasodilation & Health care. The author has an hindex of 5, co-authored 10 publications receiving 171 citations. Previous affiliations of William Benjamin Smith include Tulane University & Veterans Health Administration.

Papers
More filters
Journal ArticleDOI

PDE5 inhibitors: Considerations for preference and long-term adherence

TL;DR: The advent of phosphodiesterase type 5 inhibitors (PDE5i) has revolutionised the ED treatment landscape and provided effective, minimally invasive therapies to restore male sexual function.
Journal ArticleDOI

Medial compartment knee osteoarthritis: age-stratified cost-effectiveness of total knee arthroplasty, unicompartmental knee arthroplasty, and high tibial osteotomy

TL;DR: HTO may be the most cost-effective option when treating MCOA in younger patients, while UKA may be preferred in older patients, and functional utility is the primary driver of the cost-effectiveness of these interventions.
Journal ArticleDOI

The Rho kinase inhibitor azaindole-1 has long-acting vasodilator activity in the pulmonary vascular bed of the intact chest rat

TL;DR: The data suggest that ROCK is involved in regulating baseline tone in the pulmonary and systemic vascular beds, and that ROCK inhibition will promote vasodilation when tone is increased by diverse stimuli including treatment with monocrotaline.
Journal ArticleDOI

Impact of Longitudinal Virtual Primary Care on Diabetes Quality of Care

TL;DR: In this paper, the authors evaluated differences in diabetes care before and after implementation of a longitudinal virtual primary care program using a propensity score-matched cohort study utilizing difference-in-differences analysis and found that the virtual integrated multisite patient aligned care teams (V-IMPACT) program was effective for management of chronic conditions such as diabetes.